Introduction
To feed or breathe the oral opening must connect with the gut. The primary mouth marks the location of this interface, and perforation is essential (Dickinson and Sive, 2006; Hardin and Armstrong, 1997; McClay et al., 1992; Poelmann et al., 1985; Soukup et al., 2013; Takahama et al., 1988; Watanabe et al., 1984) . Despite the fundamental importance of the primary mouth, little is known about the molecular control of its development. In mammals, the buccopharyngeal membrane (BPM) is hidden internally, behind the expanding facial prominences and is surrounded by the brain and cardiac tissues, making mammalian primary mouth development a challenging process to investigate (Poelmann et al., 1985; Soukup et al., 2013; Theiler, 1969; Waterman, 1977) . However, a series of elegant studies have shown that Xenopus laevis is a tractable model for understanding primary mouth development (Dickinson and Sive, 2007 , 2006 , 2009 Jacox et al., 2014; Kennedy and Dickinson, 2014) .
In mammals and amphibians the mouth opening forms as a result of contact between invaginating primary mouth ectoderm and foregut endothelium (Fig. 1A ) Sive, 2006, 2009; Soukup et al., 2013; Waterman, 1977 Waterman, , 1985 Waterman and Schoenwolf, 1980) . In Xenopus, invaginating ectoderm appears as a depression called the stomodeum (Dickinson and Sive, 2006) , and this depression deepens as apoptosis and cell intermingling thin the epithelium Sive, 2006, 2009; Poelmann et al., 1985) . The basement membrane (BM) separating foregut endoderm and stomodeal ectoderm dissolves to permit intercalation of the epithelial bilayer and subsequent oral perforation Sive, 2006, 2009; Soukup et al., 2013; Waterman, 1977 Waterman, , 1985 Waterman and Schoenwolf, 1980) (Fig. 1) .
At present, only a single signaling system has been identified as a molecular regulator of primary mouth development. In Xenopus, Wnt signal inhibition is necessary for stomodeal specification and perforation (Dickinson and Sive, 2009 ). Wnt/β-catenin signaling is necessary to promote transcriptional activation of the basement membrane component fibronectin (FN) (Gradl et al., 1999) , while Wnt inhibitors Crescent and Frzb-1 are required within the stomodeum for dissolution of the basement membrane separating foregut endoderm and oral ectoderm (Dickinson and Sive, 2009 ). Loss of either inhibitor results in a small, imperforate primary mouth. Concomitantly, facial Wnt-8 gain-of-function is sufficient to suppress stomodeum formation (Dickinson and Sive, 2009 ). However, the stomodeal ectoderm becomes unresponsive to Wnts long before perforation, suggesting that Wnts do not directly control mouth opening (Dickinson and Sive, 2009) . Therefore, it is necessary to consider other signaling pathways during primary mouth morphogenesis.
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In mammals, virtually nothing is known about the molecular control of primary mouth formation, but several craniofacial syndromes, including CHARGE, Down, Holzgreve-Wagner-Rehder, Greig cephalopolydactyly syndrome (GCPS) and synostotic syndromes, as well as cleft palate, have been associated with persistent BPM (Kliegman, 2011; DéMurger et al., 2014; Pillai et al., 1990; Verma and Geller, 2009 ). Notably, Holzgreve-Wagner-Rehder syndrome involves cleft palate and postaxial polydactyly, phenotypes associated with Hh perturbation (Legius et al., 1988) . Furthermore, a recent publication reports that GCPS-characterized by mutations in the Hh effector Gli3-caused oral anomalies in all prenatal cases observed, and in one instance a complete absence of the oral opening (DéMurger et al., 2014) . We therefore tested the requirements for Hedgehog signaling during primary mouth development. We present data suggesting that Hh signaling is required for BPM dissolution in both Xenopus and mouse. Moreover, we show that Hh signaling is required in a dose-dependent fashion to control basement membrane dissolution and endoderm-ectoderm intercalation. These data significantly advance our understanding of primary mouth development and pinpoint a novel role for Hh signaling during this process.
Results and discussion

Hedgehog is required for primary mouth perforation
In Xenopus, the primary mouth is externally accessible and offers a tractable system for studying oral perforation (Dickinson and Sive, 2006) . Moreover, Xenopus embryos are easily treated with chemical modulators. Thus, early effects of Hh perturbation can be readily bypassed (Hollemann et al., 2007; Lewis and Krieg, 2014; Peyrot et al., 2011) . We asked whether Hh loss of function, using the potent inhibitor cyclopamine or SANT1, could perturb primary mouth development (Chen et al., 2002; Peyrot et al., 2011; Williams et al., 2003) . Indeed, incubation with either cyclopamine or SANT1 resulted in ablation of the stomodeum and the primary oral opening (Fig. 1B -D compared to E). Hh pathway activation is therefore essential for primary mouth development.
Hedgehog regulates primary mouth size
As loss of Hh activation resulted in a small or absent primary mouth, we asked whether increasing the levels of Hh could modulate mouth size. Purmorphamine is a well-established Hh agonist (Dessaud et al., 2007; Sinha and Chen, 2006; Stanton and Peng, 2010) , and continuous incubation of embryos with purmorphamine caused a dramatic increase in primary mouth size ( Fig. 1F -H compared to E, and I). Therefore, Hh activation is both necessary and sufficient to drive an increase in mouth size. This effect on oral size was specific, as both inhibition and activation of Hh signaling, from the 2-cell stage, resulted in broadly similar changes in head proportions (Supplemental Fig. S1D and E); despite this, cyclopamine and purmorphamine had opposing effects on the oral opening. Furthermore, the cement gland and nasal pits, two anterior structures that develop in close proximity to the mouth, were not dramatically altered upon either treatment . These data suggest that Hh-mediated regulation of primary mouth development is specific to the mouth, and can be uncoupled from early morphogenetic defects elsewhere in the craniofacial region.
We then tested whether mouth size is sensitive to graded levels of Hedgehog signaling by applying a range of drug dosages ( Fig. 1B-I ). To quantify the change in mouth size we measured the perimeter of the stomodeum after incubation with 2, 5 or 10 μM SANT1, 0.7% DMSO (control), or 2, 20, 100 μM purmorphamine. As incubation with either Hh modulator significantly decreased head size ( Fig. S1E-F ) we chose to normalize mouth perimeter to the width of the head, measured as the distance between the outer edges of the eyes. We found that increasing levels of purmorphamine caused a dose dependent enlargement in primary mouth size (Fig. 1F-I ). Conversely, cyclopamine or SANT1 treatments caused a dose dependent reduction or complete loss of the stomodeum (Fig. 1B-I ). Together, these data suggest that an intermediate level of Hh activation is required to determine normal mouth size.
The oral opening is sensitive to Hedgehog throughout development
Previous studies have shown that primary mouth specification is susceptible to Wnt manipulation for a short time window, up to stage 24, prior to appearance of the stomodeum (Dickinson and Sive, 2009 ). Therefore, we asked whether Hh activation functions throughout primary mouth development or during a brief period. We tested sensitivity to Hh perturbation during induction, basement membrane dissolution, or perforation stages by treating with either drug from the 2-cell stage, between stages 12 and 19, stages 19 and 37, or from stage 37 (see Fig. 1A ). At all stages up to perforation, we found that purmorphamine treatment was sufficient to increase mouth size (Fig. 1N-Q) . In contrast, tadpoles were sensitive to Hh inhibition only until perforation stages (stage 37) (Fig. 1I-M) . This suggests that initial specification of the mouth requires early Hh activation. However, perforation of the mouth may be separately controlled as a later increase in Hh signaling is sufficient to expand mouth size.
Hedgehog signaling regulates stomodeal basal lamina dissolution
We next sought to understand the cell biological mechanism of Hh action during primary mouth development. Prior to intercalation stages, a basement membrane comprising fibronectin and laminin separates endoderm and ectoderm (Dickinson and Sive, 2006) , and the buccopharyngeal membrane forms after contact between the foregut endoderm with stomodeal ectoderm. Endoderm-ectoderm contact initiates basal lamina dissolution, which permits cell intercalation prior to perforation (Dickinson and Sive, 2006) . Therefore, we considered whether the basement membrane component fibronectin was maintained after cyclopamine or SANT1 treatment. Fibronectin immunoreactivity marks the stomodeal BM at stage 24 (Fig. 2B) , which is lost by stage 26 (Fig. 2E) . After cyclopamine treatment, basement membrane fibronectin was maintained at stage 26 ( Fig. 2A and D) , suggesting that Hh is necessary for basement membrane dissolution.
This raised the possibility that increasing Hh activation might ectopically promote basement membrane dissolution. Indeed, in contrast to control and cyclopamine treatments, fibronectin was significantly diminished or completely absent in stage 24 purmorphamine treated embryos (Fig. 2C) . Therefore, Hh is necessary and sufficient to promote basement membrane dissolution. Precocious loss of the basement membrane could promote premature endoderm-ectoderm mixing and increase the duration or amount of intercalation. This mechanism is consistent with our observations that increased Hh activity causes a dose dependent increase in mouth size.
Previous studies suggested that basement membrane maintenance reduces mouth size by inhibiting endoderm-ectoderm intercalation and buccopharyngeal membrane formation (Dickinson and Sive, 2009 ). This prompted us to examine the BPM: in stage 39 control embryos, a one-cell thick BPM is observed indicating that endoderm and ectoderm cells have intercalated into a single cell layer (Fig. 2B) . In contrast, after cyclopamine treatment, endoderm and ectoderm were morphologically distinct ( Fig. 2A) , and the intervening mesenchyme was still present. This phenotype is consistent with a lack of mesenchymal clearance and intercalation, and suggests that Hh is required for timely BM dissolution and BPM formation.
As BM maintenance can inhibit intercalation in the stomodeum, we hypothesized that premature BM dissolution could promote intercalation and premature perforation. We compared purmorphamine treated embryos to controls at stage 39, when the buccopharyngeal membrane is evident but has thinned. The BPM was absent in embryos treated with purmorphamine (compare Fig. 2L to K) . Therefore, Hh activation is sufficient to promote premature perforation and primary mouth opening.
Stomodeal inhibition of Wnt is downstream of Hh signaling
Basement membrane dissolution is expedited after either gain of Hh signaling (Fig. 2) or loss of the Wnt inhibitors Frzb-1 and Crescent (Dickinson and Sive, 2009) . Our data suggest that Hh signals are required for stomodeal formation during an earlier developmental window than that reported for stomodeal Frzb-1 or Crescent. Therefore, we asked if Wnt signal inhibition functions downstream of Hh activation in determining primary mouth size (Fig. 3) . In this case, activation of Wnt should be able to rescue mouth enlargement caused by Hh gain of function. To test this, we first treated embryos with DMSO or purmorphamine at the 2-cell stage. After washout at stage 12.5 or 19, embryos were treated with a glycogen synthase kinase-3 (GSK-3) inhibitor, BIO, which activates β-catenin dependent Wnt signaling (Meijer et al., 2003) .
Consistent with previous reports on Wnt inhibition (Dickinson and Sive, 2009 ), BIO treatment during neurulation (stage 12.5-19), after incubation with DMSO (2 cell-stage-12.5), caused a complete loss of the mouth (Fig. 3B) , while BIO treatment from stage 19 did not affect mouth size (Fig. 3C ). Embryos treated with BIO from stage 12.5, after incubation with purmorphamine, showed a reversal of purmorphamine induced stomodeal expansion, with a complete loss of the oral opening (compare Fig. 3E to D) . Conversely, BIO treatment from stage 19, after incubation with purmorphamine, was unable to reverse the effect of increased Hh signaling (Fig. 3F) . These data suggest that stomodeum is refractory to inhibition of Wnt signals after stage 19, consistent with previous reports showing that Frzb-1/Crescent needs to be down regulated after stage 19 (Dickinson and Sive, 2009) .
As Hh and Wnt signaling function antagonistically in many contexts (Akiyoshi, 2006; Cain et al., 2009; He et al., 2006; Lee et al., 2000; Varnat et al., 2010; Wheway et al., 2013) , we propose that SHH signals, expressed in the prechordal plate (Ekker et al., 1995) , activates facial Wnt inhibitor expression, such as Crescent and Frzb-1, which in turn mediates basal lamina dissolution (Dickinson and Sive, 2009) . As prolonged Hh signaling causes continued enlargement of the mouth, but Wnt sensitivity is short-lived, Hh is likely to act independently of Wnt during later oral opening (Fig. 4D) .
Hh regulates mammalian BPM perforation
Our data demonstrate a key role for Hh signaling in Xenopus mouth development; genetic evidence suggests that this is also the case in humans (DéMurger et al., 2014; Legius et al., 1988) . To ask if Hh loss of function might perturb mammalian BPM perforation, we examined mice mutant for Sonic hedgehog (Shh).
In humans, the BPM disappears by 15 days gestation, while in mice perforation of the BPM occurs by the 17-somite stage at E9 (Poelmann et al., 1985; Theiler, 1969; Standring, 2009 ). Strikingly, cross sections of E9 embryos revealed that the BPM was inappropriately retained in Shh mutants (Fig. 4C) .
In humans, Greig cephalopolydactyly (GCPS) and Pallister-Hall syndromes are caused by mutation of the Hedgehog effector Gli3 (DéMurger et al., 2014; Legius et al., 1988) . Both syndromes are associated with an absence of oral perforation (DéMurger et al., 2014) . We examined BPM perforation using mice carrying the Gli3 xt-J allele which models GCPS (Hui and Joyner, 1993) . We found that loss of Gli3 in this mutant was sufficient to retard dissolution of the BPM (Fig. 4D and E) . This outcome is of interest because it provides insights into the mechanism of Gli3 action. Biochemically, Gli3 is a transcription factor; it is believed that in the absence of Hh, Gli3 represses Hh target genes, while Hh activation converts Gli3 into a transcriptional activator (Blaess et al., 2008; Wang et al., 2007) . Our data are notable because in the context of human Gli3 mutations, it has been unclear whether the oral phenotypes reflect a requirement for Gli3 as a transcriptional activator or as a repressor (DéMurger et al., 2014) . Because BPM persistence in Gli3 xt-J/xt-J mice phenocopies Shh mutant mice, our data support the argument that Gli3 acts as a transcriptional activator during oral perforation. Anatomical characterization in diverse systems including sea urchins, urodeles, Xenopus, and mouse have suggested that interactions between foregut and stomodeal ectoderm are important for oral perforation (Dickinson and Sive, 2006; Hardin and Armstrong, 1997; McClay et al., 1992; Poelmann et al., 1985; Soukup et al., 2013; Takahama et al., 1988; Theiler, 1969; Watanabe et al., 1984; Waterman, 1977) . However, molecular regulation of primary mouth opening is largely untested, especially as perforation occurs early in development and perturbation of major signaling cascades results in broad cranial defects. Moreover, because the mammalian primary mouth develops internally, defects in its development are obscured by secondary oral phenotypes. Indeed, the evidence of human BPM anomalies is primarily anecdotal and persistent BPM is frequently unreported due to the severity of associated phenotypes (Verma and Geller, 2009) .
Taken together, we provide the first demonstration of a role for HH signaling in primary mouth development, and moreover we provide the first data directly revealing a molecular mechanism in mammalian BPM development. Our data suggest that HH and Gli3 are required to drive basement membrane dissolution, endodermectoderm intercalation and perforation of the primary mouth. These experiments also illustrate the feasibility of using Xenopus to provide testable hypotheses in mammals. Combined, these data provide novel evolutionary insights into the genetic regulation governing oral opening, and may be relevant to poorly studied human anomalies, such as persistent BPM and atresia.
Materials and methods
Animals
X. laevis embryos were cultured using standard methods (Sive et al., 2000) . Staging was according to Nieuwkoop and Faber (1994) . Shh mutants were initially generated by crossing floxed mutants to Sox2-Cre (Lewis et al., 2001) . Gli3 xt-J is a spontaneously occurring intergenic deletion of Gli3 (Hui and Joyner, 1993) . Mice were a kind gift from Dr. Steven Vokes.
Chemical inhibitors
Xenopus embryos were incubated in 12-well plates, 10 embryos per well. For Hh perturbation 250 μM, 50 μM, or 5 μM cyclopamine (Cayman Chemicals), 20 μM, 5 μM, or 2 μM SANT1 (Sigma), or 2 μM, 20 μM, or 100 μM purmorphamine (inSolution, Sigma) were added to media. Control embryos were incubated in 0.7% DMSO in media. For single dose experiments 250 μM cyclopamine, 20 μM SANT1 and 100 μM purmorphamine were used.
Immunohistochemistry
Immunohistochemistry was performed according to standard protocols using a polyclonal anti-β-catenin antibody (Santa 
